Bioerodible Self-Deploying Intragastric Implants

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current intragastric volume-occupying devices for obesity management often require surgical procedures for placement and lack a bioerodible, self-deploying implant that can be swallowed and self-inflate within the stomach to curb appetite effectively.

Innovation Solution

Development of bioerodible, self-deploying intragastric implants constructed from discrete expandable members that inflate using a swallowed gas-producing composition, providing pressure on the stomach wall to induce satiety without external inflating valving, and dissolving or degrading after a selected period.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If traditional intragastric volume-occupying devices are used, then satiety effect is achieved, but surgical intervention is required for placement

Engineering Contradiction:
Improveease of placementVSAvoidplacement procedure complexity
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The implant is designed to be self-deploying and self-inflating upon swallowing. The device automatically expands within the stomach using gas-producing composition without requiring external inflating valving or surgical intervention, allowing the patient to administer the implant orally and achieve satiety effect independently

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent replaces complex mechanical inflating systems with a chemical gas-producing composition. Instead of using external valves and mechanical inflation devices, the implant utilizes a swallowed gas-producing composition that chemically generates gas to inflate the implant automatically within the stomach

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Duration of action of moving object

If bioerodible materials are used for the implant, then dissolution after selected period is achieved, but manufacturing precision requirements increase

Engineering Contradiction:
Improveresidence time in stomachVSAvoiderosion rate control precision
Core Design Contradiction:
Duration of action of moving objectVSManufacturing precision

Solution Approach 1:

The patent controls the dissolution rate by adjusting material parameters such as polymer composition, molecular weight, and crystallinity. The bioerodible polymer composition is specifically selected to provide controlled erosion rates that match the desired residence time in the stomach, allowing precise control over implant degradation without requiring complex manufacturing tolerances

Inventive Principle:
Principle #35Parameter changes

3Extent of automation

If discrete expandable members are used, then self-deployment is achieved, but device complexity increases

Engineering Contradiction:
Improveself-deployment capabilityVSAvoidstructure complexity
Core Design Contradiction:
Extent of automationVSDevice complexity

Solution Approach 1:

The implant is constructed from discrete expandable members that can be independently deployed within the stomach. This segmentation allows the device to be assembled from multiple simpler components rather than requiring a single complex structure, achieving self-deployment through the coordinated expansion of individual members while maintaining overall device manageability

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The implants effectively reduce food intake by providing a feeling of fullness without surgical intervention, offering a cost-effective, biodegradable solution tailored to individual patient needs, with adjustable expansion and dissolution times based on patient characteristics.

Implementation Method 1

The implant may be constructed from one or more discrete expandable members. The implants may be swallowed and may be self-deployable. Also described are treatments for curbing an individual's appetite by using those devices.

Methodology Applied
Scientific EffectChemical reaction: Chemical Bonding

Implementation Method 2

bioerodible, biodegradable, or digestible self-deploying intragastric implants that may be swallowed. The implants then dissolve or are disassembled perhaps using gastric liquids

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentUS7699863B2Bioerodible self-deployable intragastric implants
Publication Date: 2010.04.20 TULIP MEDICAL LTD
  • US7699863B2 patent drawing
  • US7699863B2 patent drawing
  • US7699863B2 patent drawing

AI summary

Described herein are bioerodible, biodegradable, or digestible self-deploying intragastric implants that may be swallowed. Once swallowed, the implants undergo self-expansion in the stomach and apply a suitable pressure against the stomach wall to provide a feeling of satiety to the individual. The implants then dissolve or are disassembled perhaps using gastric liquids and pass out of the stomach. Methods of using the devices, perhaps for an individual participating in a dietary control regimen, are described.